Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06260033

Phase 2, Recruiting

Patient Derived Preclinical Models

for
Cancer
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05324553

Recruiting

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

for
Breast Cancer
Location: Houston TX, Dallas TX, Seattle WA
Sponsor: ARTIDIS AG

Sex: All

Age: 18+

Code: NCT06085833

Recruiting

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

for
Colorectal Cancer, Metastatic Cancer
Location: Goshen IN
Sponsor: Goshen Health System

Sex: All

Age: 18+

Code: NCT00408551

Phase 2, Recruiting

A Novel Approach Utilizing Organ Specific Age Proteomics

for
Breast Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 22 - 66

Code: NCT06789653

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer

for
Breast Cancer, Prostate Cancer, Vertebral Metastasis, Pain
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 35 - 70+

Code: NCT00294151

Phase 3, Recruiting

The Radiation Oncology Registry and Biosample Repository

for
Neoplasia
Location: Voorhees Township NJ, Philadelphia PA, Lancaster PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT01577251

Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

for
Metastatic Hepatocellular Carcinoma, Solid Tumors,
Location: Boston MA, New York NY, Baltimore MD, Toronto,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06915753

Phase 1, Recruiting

PediRISE Feasibility

for
Pediatric Cancer, Financial Stress, Financial Hardship,
Location: Boston MA, New York NY, San Francisco CA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 17

Code: NCT06283251

Recruiting

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Los Angeles CA
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT04219254

Phase 1, Phase 2, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, New York NY, Baltimore MD,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase 1, Recruiting

Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems

for
Architectural Distortions, Breast Tomosynthesis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 0+

Code: NCT06373354

Recruiting

Optimizing Surgical Decisions in Young Adults With Breast Cancer

for
Breast Cancer Stage 0, Breast Cancer Stage I,
Location: Boston MA, New Haven CT, New York NY, Durham NC
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 44

Code: NCT06275126

Recruiting

A Study of Mental Health Care in People With Cancer

for
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 65+

Code: NCT06037954

Recruiting

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

for
Malignant Neoplasm of Breast
Location: New Haven CT, Buffalo NY, Rancho Mirage CA, La Jolla CA
Sponsor: Novian Health Inc.

Sex: Female

Age: 18+

Code: NCT03463954

Recruiting

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Dallas TX
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT05244551

Phase 1, Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Boston MA, Mineola NY, New Hyde Park NY, The Bronx NY,
Sponsor: Hoth Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05639933

Phase 2, Recruiting

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT04526587

Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

for
Breast Cancer, Ovarian Cancer, Gynecologic Cancers,
Location: Stanford CA
Sponsor: Stanford University

Sex: Female

Age: 18+

Code: NCT01034033

Recruiting

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

for
Melanoma Stage IV, Solid Tumor
Location: Boston MA, New York NY, Richmond VA, Cincinnati OH,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06425926

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial